Dalbavancin as Secondary Therapy for Serious Staphylococcus aureus Infections in a Vulnerable Patient Population-Reference-Cited by-同舟云学术

Dalbavancin as Secondary Therapy for Serious Staphylococcus aureus Infections in a Vulnerable Patient Population

Published:2019-01-30 Issue:2 Volume:6 Page:
ISSN:2328-8957
Container-title:Open Forum Infectious Diseases
language:en
Short-container-title:

Author:

Bryson-Cahn Chloe¹²^ORCID,Beieler Alison M¹²^ORCID,Chan Jeannie D¹²³,Harrington Robert D¹²,Dhanireddy Shireesha¹²^ORCID

Affiliation:

1. Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, School of Medicine, Seattle, Washington

2. Harborview Medical Center, Seattle, Washington

3. School of Pharmacy, University of Washington, Seattle, Washington

Abstract

Abstract We retrospectively evaluated off-label use of dalbavancin as secondary therapy in 32 patients with serious Staphylococcus aureus infections (endocarditis, osteomyelitis, septic thrombophlebitis, epidural infection) who were also persons who use drugs. The majority of patients (56%) had a clinical response to treatment. Only 1 patient who completed the intended dalbavancin course experienced a treatment failure.

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Oncology

Link

http://academic.oup.com/ofid/article-pdf/6/2/ofz028/33575442/ofz028.pdf

Reference17 articles.

1. Dalbavancin in the treatment of different gram-positive infections: a real-life experience;Bouza;Int J Antimicrob Agents,2018

2. Dalbavancin as primary and sequential treatment for Gram-positive infective endocarditis: 2-year experience at the General Hospital of Vienna;Tobudic;Clin Infect Dis,2018

3. Practice guidelines for outpatient parenteral antimicrobial therapy. IDSA guidelines;Tice;Clin Infect Dis,2004

4. Successful implementation of outpatient parenteral antimicrobial therapy at a medical respite facility for homeless patients;Beieler;J Hosp Med,2016

5. Oral parenteral antimicrobial therapy administration in a homeless population;Hernandez;J Infus Nurs,2016

Cited by 63 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. How I manage severe bacterial infections in people who inject drugs;Clinical Microbiology and Infection;2024-07

2. Chronic antibiotic suppressive therapy with dalbavancin: a case series;Journal of Chemotherapy;2024-05-07

3. Three-years of dalbavancin use at a UK tertiary referral hospital serving a population with high numbers of people who inject drugs;JAC-Antimicrobial Resistance;2024-05-06

4. Real-World Dalbavancin Use for Serious Gram-Positive Infections: Comparing Outcomes Between People Who Use and Do Not Use Drugs;Open Forum Infectious Diseases;2024-03-28

5. New Frontier on Antimicrobial Therapy: Long-Acting Lipoglycopeptides;Pathogens;2024-02-20